Database Query Results : Trastuzumab, ,
Tras, Trastuzumab: Click to Expand ⟱
| Features: |
Trastuzumab is a targeted therapy used in the treatment of certain types of cancer, most notably HER2-positive breast cancer.
It specifically targets the human epidermal growth factor receptor 2 (HER2), a protein that is overexpressed in some types of breast cancer and other cancers.
-Is a Her2 inhibitor used in breast cancer.
Trastuzumab has revolutionized the treatment of HER2-positive breast cancer, significantly improving both response rates and overall survival.
|
Scientific Papers found: Click to Expand⟱
tumCV↓, eff↑, P53↑, BAX↑, Casp3↑, Casp8↑, Bcl-2↓, Apoptosis↑, p‑p38↓, ERK↓, PI3K↓,
ChemoSen↑, HER2/EBBR2↓, PI3K↓, Akt↓, mTOR↓, p62↑,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp3↑, 1, Casp8↑, 1, p‑p38↓, 1,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Autophagy & Lysosomes ⓘ
p62↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, mTOR↓, 1, PI3K↓, 2,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, eff↑, 1,
Clinical Biomarkers ⓘ
HER2/EBBR2↓, 1,
Total Targets: 17
Pathway results for Effect on Normal Cells:
Total Targets: 0
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:260 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page